Castle M, Flanigan M
Neurobiol Stress. 2024; 30:100618.
PMID: 38433994
PMC: 10907856.
DOI: 10.1016/j.ynstr.2024.100618.
Hoffman J, Faccidomo S, Saunders B, Taylor S, Kim M, Hodge C
Alcohol Clin Exp Res. 2021; 45(7):1424-1435.
PMID: 34086361
PMC: 8336716.
DOI: 10.1111/acer.14639.
Faccidomo S, Swaim K, Saunders B, Santanam T, Taylor S, Kim M
Psychopharmacology (Berl). 2018; 235(6):1681-1696.
PMID: 29502276
PMC: 5949261.
DOI: 10.1007/s00213-018-4870-3.
Alvarez-Jaimes L, Polis I, Parsons L
Open Neuropsychopharmacol J. 2016; 2:77-85.
PMID: 27974944
PMC: 5152943.
DOI: 10.2174/1876523800902020077.
Faccidomo S, Salling M, Galunas C, Hodge C
Psychopharmacology (Berl). 2015; 232(18):3417-30.
PMID: 26123321
PMC: 4537834.
DOI: 10.1007/s00213-015-3993-z.
Molecular basis of alcoholism.
Most D, Ferguson L, Harris R
Handb Clin Neurol. 2014; 125:89-111.
PMID: 25307570
PMC: 4280079.
DOI: 10.1016/B978-0-444-62619-6.00006-9.
Overexpression of the steroidogenic enzyme cytochrome P450 side chain cleavage in the ventral tegmental area increases 3α,5α-THP and reduces long-term operant ethanol self-administration.
Cook J, Werner D, Maldonado-Devincci A, Leonard M, Fisher K, OBuckley T
J Neurosci. 2014; 34(17):5824-34.
PMID: 24760842
PMC: 3996211.
DOI: 10.1523/JNEUROSCI.4733-13.2014.
Enhanced AMPA receptor activity increases operant alcohol self-administration and cue-induced reinstatement.
Cannady R, Fisher K, Durant B, Besheer J, Hodge C
Addict Biol. 2012; 18(1):54-65.
PMID: 23126443
PMC: 3535558.
DOI: 10.1111/adb.12000.
Fluorophore assisted light inactivation (FALI) of recombinant 5-HT₃A receptor constitutive internalization and function.
Morton R, Luo G, Davis M, Hales T, Lovinger D
Mol Cell Neurosci. 2011; 47(2):79-92.
PMID: 21338684
PMC: 3172681.
DOI: 10.1016/j.mcn.2011.02.007.
A double-blind, randomized trial of sertraline for alcohol dependence: moderation by age of onset [corrected] and 5-hydroxytryptamine transporter-linked promoter region genotype.
Kranzler H, Armeli S, Tennen H, Covault J, Feinn R, Arias A
J Clin Psychopharmacol. 2010; 31(1):22-30.
PMID: 21192139
PMC: 3130300.
DOI: 10.1097/JCP.0b013e31820465fa.
Serotonin-3 receptors in the posterior ventral tegmental area regulate ethanol self-administration of alcohol-preferring (P) rats.
Rodd Z, Bell R, Oster S, Toalston J, Pommer T, McBride W
Alcohol. 2010; 44(3):245-55.
PMID: 20682192
PMC: 4516283.
DOI: 10.1016/j.alcohol.2010.01.002.
The role of 5-HT3 receptors in drug abuse and as a target for pharmacotherapy.
Engleman E, Rodd Z, Bell R, Murphy J
CNS Neurol Disord Drug Targets. 2009; 7(5):454-67.
PMID: 19128203
PMC: 2878195.
DOI: 10.2174/187152708786927886.
Distinct subsets of nucleus accumbens neurons encode operant responding for ethanol versus water.
Robinson D, Carelli R
Eur J Neurosci. 2008; 28(9):1887-94.
PMID: 18973602
PMC: 2597565.
DOI: 10.1111/j.1460-9568.2008.06464.x.
Cue-induced reinstatement of alcohol-seeking behavior is associated with increased ERK1/2 phosphorylation in specific limbic brain regions: blockade by the mGluR5 antagonist MPEP.
Schroeder J, Spanos M, Stevenson J, Besheer J, Salling M, Hodge C
Neuropharmacology. 2008; 55(4):546-54.
PMID: 18619984
PMC: 2613007.
DOI: 10.1016/j.neuropharm.2008.06.057.
Update on neuropharmacological treatments for alcoholism: scientific basis and clinical findings.
Johnson B
Biochem Pharmacol. 2007; 75(1):34-56.
PMID: 17880925
PMC: 2359153.
DOI: 10.1016/j.bcp.2007.08.005.
The 5-HT3 receptor as a therapeutic target.
Thompson A, Lummis S
Expert Opin Ther Targets. 2007; 11(4):527-40.
PMID: 17373882
PMC: 1994432.
DOI: 10.1517/14728222.11.4.527.
5-HT3 receptors.
Thompson A, Lummis S
Curr Pharm Des. 2006; 12(28):3615-30.
PMID: 17073663
PMC: 2664614.
DOI: 10.2174/138161206778522029.
Effects of dexfenfluramine and 5-HT3 receptor antagonists on stress-induced reinstatement of alcohol seeking in rats.
Le A, Funk D, Harding S, Juzytsch W, Fletcher P, Shaham Y
Psychopharmacology (Berl). 2006; 186(1):82-92.
PMID: 16521030
DOI: 10.1007/s00213-006-0346-y.
The mGluR5 antagonist MPEP selectively inhibits the onset and maintenance of ethanol self-administration in C57BL/6J mice.
Hodge C, Miles M, Sharko A, Stevenson R, Hillmann J, Lepoutre V
Psychopharmacology (Berl). 2005; 183(4):429-38.
PMID: 16292590
PMC: 2854492.
DOI: 10.1007/s00213-005-0217-y.
Role of the serotonergic system in the neurobiology of alcoholism: implications for treatment.
Johnson B
CNS Drugs. 2004; 18(15):1105-18.
PMID: 15581381
DOI: 10.2165/00023210-200418150-00005.